Solventum Corporation (SOLV)
74.00 x 1 78.60 x 1
Post-market by (Cboe BZX)
74.75 -0.76 (-1.01%) 03/28/25 [NYSE]
74.00 x 1 78.60 x 1
Post-market 74.75 unch (unch) 17:42 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Sales | 8,254,000 | 8,197,000 | 8,130,000 |
| Cost of Goods | 3,661,000 | 3,504,000 | 3,435,000 |
| Gross Profit | 4,593,000 | 4,693,000 | 4,695,000 |
| Operating Expenses | 3,557,000 | 3,001,000 | 3,002,000 |
| Operating Income | 1,036,000 | 1,692,000 | 1,693,000 |
| Interest Expense | 367,000 | 0 | 0 |
| Other Income | -64,000 | -25,000 | -1,000 |
| Pre-tax Income | 605,000 | 1,667,000 | 1,692,000 |
| Income Tax | 127,000 | 321,000 | 349,000 |
| Net Income Continuous | 478,000 | 1,346,000 | 1,343,000 |
| Net Income | $478,000 | $1,346,000 | $1,343,000 |
| EPS Basic Total Ops | 2.77 | 7.79 | 7.78 |
| EPS Basic Continuous Ops | 2.76 | 7.79 | 7.78 |
| EPS Diluted Total Ops | 2.76 | 7.79 | 7.78 |
| EPS Diluted Continuous Ops | 2.75 | 7.79 | 7.78 |
| EPS Diluted Before Non-Recurring Items | 6.70 | N/A | N/A |
| EBITDA(a) | $1,591,000 | $2,253,000 | $2,271,000 |